Advertisement

Pantoprazole Tablets

[16 September 2014]

Products Affected - Description

Pantoprazole Tablets, Actavis
20 mg tablets, 90 count (NDC 45963-0569-08)
40 mg tablets, 90 count (NDC 45963-0570-08)

40 mg tablets, 1000 count (NDC 45963-0570-05) - discontinued   
 
Pantoprazole Tablets, Aurobindo
20 mg tablets, 90 count (NDC 65862-0559-90)
40 mg tablets, 90 count (NDC 65862-0560-90)
 
Pantoprazole Tablets, Kremers Urban
20 mg tablets, 90 count (NDC 62175-0180-46)
40 mg tablets, 90 count (NDC 62175-0181-46)
 
Pantoprazole Tablets, Mylan
20 mg tablets, 90 count (NDC 00378-6688-77)

 
Pantoprazole Tablets, Prasco
20 mg tablets, 90 count (NDC 00008-0606-01)
40 mg tablets, 90 count (NDC 00008-0607-01)
40 mg tablets, 100 count, unit-dose (NDC 00008-0607-04)
 
Pantoprazole Tablets, Teva
20 mg tablets, 90 count (NDC 00093-0011-98)
 
Pantoprazole Tablets, Torrent
20 mg tablets, 90 count (NDC 13668-0096-90)
40 mg tablets, 90 count (NDC 13668-0429-90)
 
Pantoprazole Tablets, Wockhardt
20 mg tablets, 90 count (NDC 64679-0433-04)
20 mg tablets, 1000 count (NDC 64679-0433-02)
40 mg tablets, 90 count (NDC 64679-0434-04)
40 mg tablets, 1000 count (NDC 64679-0434-02) 

Reason for the Shortage

  • Actavis, Aurobindo, Mylan, Teva, and Torrent could not provide a reason for the shortage.
  • Kremers Urban state the shortage is due to increased demand.
  • FDA imposed an import ban in mid-2013 on several Wockhardt products including pantoprazole.

Available Products

Pantoprazole Tablets, Caraco
40 mg tablets, 90 count (NDC 47335-0580-81)
 
Pantoprazole Tablets, Major
40 mg tablets, 100 count (NDC 00904-6235-61)

Pantoprazole Tablets, Mylan Institutional
40 mg tablets, 100 count (NDC 51079-0051-20)
 
Pantoprazole Tablets, Mylan
40 mg tablets, 90 count (NDC 00378-6689-77)
40 mg tablets, 1000 count (NDC 00378-6689-10)

Pantoprazole Tablets, Teva
40 mg tablets, 90 count (NDC 00093-0012-98)
 
Protonix Tablets, Pfizer
20 mg tablets, 90 count (NDC 00008-0843-81)
40 mg tablets, 90 count (NDC 00008-0841-81)
40 mg tablets, 100 count (NDC 00008-0841-99)

Estimated Resupply Dates

  • Actavis has pantoprazole 20 mg and 40 mg tablets on back order and the company cannot estimate a release date.
  • Aurobindo has pantoprazole 20 mg and 40 mg tablets on intermittent back order and the company is releasing supplies as they become available. 
  • Kremers Urban is allocating pantoprazole weekly.
  • Mylan has pantoprazole 20 mg tablets on back order and the company estimates a release date in mid-October 2014.  
  • Prasco has pantoprazole presentations on intermittent back order and the company is releasing supplies as they become available.
  • Teva has pantoprazole 20 mg tablets on back order and the company estimates a release date in early-October 2014.
  • Torrent has pantoprazole 20 mg and 40 mg tablets in 90 count bottles on back order and the company cannot estimate a release date. 
  • Wockhardt has pantoprazole tablets on back order and the company cannot estimate a release date.

Related Shortages

Updated

September 16, 2014; August 15, 2014; August 1, 2014; July 9, 2014; June 26, 2014; June 5, 2014; May 5, 2014; April 28, 2014; April 15, 2014; March 28, 2014; February 27, 2014; February 4, 2014; December 18, 2013; December 4, 2013; November 11, 2013; November 8, 2013; September 26, 2013; September 3, 2013; August 20, 2013; August 1, 2013; July 2, 2013; June 27, 2013; May 22, 2013; May 10, 2013; April 3, 2013; March 1, 2013; February 14, 2013; February 1, 2013; January 25, 2013; January 11, 2013; December 19, 2012; December 5, 2012, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement